Magdolen V - Search Results

1

tRNA^GlyGCC-Derived Internal Fragment (i-tRF-GlyGCC) in Ovarian Cancer Treatment Outcome and Progression.

Panoutsopoulou K, Dreyer T, Dorn J, Obermayr E, Mahner S, Gorp TV, Braicu I, Zeillinger R, Magdolen V, Avgeris M, Scorilas A. Panoutsopoulou K, et al. Among authors: magdolen v. Cancers (Basel). 2021 Dec 22;14(1):24. doi: 10.3390/cancers14010024. Cancers (Basel). 2021. PMID: 35008188 Free PMC article.

2

Disease processes may be reflected by correlations among tissue kallikrein proteases but not with proteolytic factors uPA and PAI-1 in primary ovarian carcinoma.

Dorn J, Harbeck N, Kates R, Magdolen V, Grass L, Soosaipillai A, Schmalfeldt B, Diamandis EP, Schmitt M. Dorn J, et al. Among authors: magdolen v. Biol Chem. 2006 Aug;387(8):1121-8. doi: 10.1515/BC.2006.138. Biol Chem. 2006. PMID: 16895483

3

Circulating biomarker tissue kallikrein-related peptidase KLK5 impacts ovarian cancer patients' survival.

Dorn J, Magdolen V, Gkazepis A, Gerte T, Harlozinska A, Sedlaczek P, Diamandis EP, Schuster T, Harbeck N, Kiechle M, Schmitt M. Dorn J, et al. Among authors: magdolen v. Ann Oncol. 2011 Aug;22(8):1783-90. doi: 10.1093/annonc/mdq701. Epub 2011 Jan 27. Ann Oncol. 2011. PMID: 21273346 Free article.

4

mRNA expression levels of the biological factors uPAR, uPAR-del4/5, and rab31, displaying prognostic value in breast cancer, are not clinically relevant in advanced ovarian cancer.

Kotzsch M, Dorn J, Doetzer K, Schmalfeldt B, Krol J, Baretton G, Kiechle M, Schmitt M, Magdolen V. Kotzsch M, et al. Among authors: magdolen v. Biol Chem. 2011 Nov;392(11):1047-51. doi: 10.1515/BC.2011.166. Biol Chem. 2011. PMID: 21848504

5

Emerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignancies.

Schmitt M, Magdolen V, Yang F, Kiechle M, Bayani J, Yousef GM, Scorilas A, Diamandis EP, Dorn J. Schmitt M, et al. Among authors: magdolen v. Radiol Oncol. 2013 Oct 8;47(4):319-29. doi: 10.2478/raon-2013-0053. eCollection 2013. Radiol Oncol. 2013. PMID: 24294176 Free PMC article. Review.

6

Function and clinical relevance of kallikrein-related peptidases and other serine proteases in gynecological cancers.

Dorn J, Beaufort N, Schmitt M, Diamandis EP, Goettig P, Magdolen V. Dorn J, et al. Among authors: magdolen v. Crit Rev Clin Lab Sci. 2014 Apr;51(2):63-84. doi: 10.3109/10408363.2013.865701. Epub 2014 Feb 3. Crit Rev Clin Lab Sci. 2014. PMID: 24490956 Review.

7

Assessment of kallikrein-related peptidase 5 (KLK5) protein expression in tumor tissue of advanced ovarian cancer patients by immunohistochemistry and ELISA: correlation with clinical outcome.

Dorn J, Yassouridis A, Walch A, Diamandis EP, Schmitt M, Kiechle M, Wang P, Drecoll E, Schmalfeldt B, Loessner D, Kotzsch M, Magdolen V. Dorn J, et al. Among authors: magdolen v. Am J Cancer Res. 2015 Dec 15;6(1):61-70. eCollection 2016. Am J Cancer Res. 2015. PMID: 27073723 Free PMC article.

8

Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.

Geng X, Liu Y, Diersch S, Kotzsch M, Grill S, Weichert W, Kiechle M, Magdolen V, Dorn J. Geng X, et al. Among authors: magdolen v. PLoS One. 2017 Nov 2;12(11):e0186847. doi: 10.1371/journal.pone.0186847. eCollection 2017. PLoS One. 2017. PMID: 29095848 Free PMC article.

9

PITX2 DNA-methylation predicts response to anthracycline-based adjuvant chemotherapy in triple-negative breast cancer patients.

Absmaier M, Napieralski R, Schuster T, Aubele M, Walch A, Magdolen V, Dorn J, Gross E, Harbeck N, Noske A, Kiechle M, Schmitt M. Absmaier M, et al. Among authors: magdolen v. Int J Oncol. 2018 Mar;52(3):755-767. doi: 10.3892/ijo.2018.4241. Epub 2018 Jan 8. Int J Oncol. 2018. PMID: 29328369 Free PMC article.

10

Advanced high-grade serous ovarian cancer: inverse association of KLK13 and KLK14 mRNA levels in tumor tissue and patients' prognosis.

Dettmar L, Ahmed N, Kotzsch M, Diersch S, Napieralski R, Darmoul D, Schmitt M, Weichert W, Kiechle M, Dorn J, Magdolen V. Dettmar L, et al. Among authors: magdolen v. J Cancer Res Clin Oncol. 2018 Jun;144(6):1109-1118. doi: 10.1007/s00432-018-2623-7. Epub 2018 Mar 15. J Cancer Res Clin Oncol. 2018. PMID: 29546479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters